SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-217477
Filing Date
2019-08-09
Accepted
2019-08-09 07:53:08
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d703298d10q.htm 10-Q 434352
2 EX-31.1 d703298dex311.htm EX-31.1 11055
3 EX-31.2 d703298dex312.htm EX-31.2 11049
4 EX-32.1 d703298dex321.htm EX-32.1 4875
5 EX-32.2 d703298dex322.htm EX-32.2 4869
  Complete submission text file 0001193125-19-217477.txt   2963570

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20190630.xml EX-101.INS 472781
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20190630.xsd EX-101.SCH 33412
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20190630_cal.xml EX-101.CAL 20994
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20190630_def.xml EX-101.DEF 231118
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20190630_lab.xml EX-101.LAB 280997
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20190630_pre.xml EX-101.PRE 266780
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 191011332
SIC: 2834 Pharmaceutical Preparations